The effect of the Litcubanine A on the treatment of murine experimental periodontitis by inhibiting monocyte–macrophage chemotaxis and osteoclast differentiation

Journal of Periodontal Research
2023.0

Abstract

Background: Periodontal disease is an inflammatory disease of periodontal tissues that is closely connected with systemic diseases. During periodontitis, the inappropriate recruitment and activation of monocytes–macrophages causes an increase in osteoclast activity and disrupts bone homeostasis. Therefore, it is a promising therapeutic strategy to treat periodontitis by regulating the functions of monocytes–macrophages. Litcubanine A (LA) is an isoquinoline alkaloid extracted from the traditional Chinese medicine Litsea cubeba, which was proven to have reproducible anti-inflammatory effects, but its regulatory role on bone homeostasis in periodontitis is still not clear. Methods: In this study, zebrafish experiments and a mouse ligature-induced periodontitis model were performed, and histological analysis was used to investigate the effect of LA on macrophage chemotaxis under the inflammatory environment. Real-time PCR was used to detect the regulatory effect of LA (100 nM ~ 100 μM) on the chemotaxis function of macrophages induced by LPS. Apoptosis assay and flow cytometry were used to elucidate the influence of LA on macrophage apoptosis and proliferation. To further clarify the regulatory role of LA on macrophage osteoclast differentiation, real-time PCR, histological analysis, western blot, and micro-computed tomography (micro-CT) were performed in vivo and in vitro to verify the impact of LA on bone homeostasis. Results: Compared with the control group, the chemotaxis function of macrophage was significantly attenuated by LA in vivo. LA could significantly inhibit the expression of genes encoding the chemokine receptors Ccr1 and Cxcr4, and its ligand chemokine Cxcl12 in macrophages, and suppresses the differentiation of osteoclastic precursors to osteoclasts through the MAPK signaling pathway. There were significantly lower osteoclast differentiation and bone loss in the LA group compared with the control in the ligature-induced periodontitis model. Conclusion: LA is a promising candidate for the treatment of periodontitis through its reproducible functions of inhibiting monocyte–macrophage chemotaxis and osteoclast differentiation. © 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Knowledge Graph

Similar Paper

The effect of the Litcubanine A on the treatment of murine experimental periodontitis by inhibiting monocyte–macrophage chemotaxis and osteoclast differentiation
Journal of Periodontal Research 2023.0
The effect of an isoquinoline alkaloid on treatment of periodontitis by regulating the neutrophils chemotaxis
Journal of Leukocyte Biology 2021.0
Novel Isoquinoline Alkaloid Litcubanine A - A Potential Anti-Inflammatory Candidate
Frontiers in Immunology 2021.0
Cynaropicrin from Cynara scolymus L. suppresses Porphyromonas gingivalis LPS-induced production of inflammatory cytokines in human gingival fibroblasts and RANKL-induced osteoclast differentiation in RAW264.7 cells
Journal of Natural Medicines 2019.0
Halofuginone functions as a therapeutic drug for chronic periodontitis in a mouse model
International Journal of Immunopathology and Pharmacology 2020.0
Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/ MMP9 pathway and prevents inflammatory bone destruction
Phytomedicine 2022.0
α-Lipoic Acid Inhibits Inflammatory Bone Resorption by Suppressing Prostaglandin E2 Synthesis
The Journal of Immunology 2006.0
<scp>l</scp>‐tetrahydropalmatine suppresses osteoclastogenesis in vivo and in vitro via blocking RANK‐TRAF6 interactions and inhibiting NF‐κB and MAPK pathways
Journal of Cellular and Molecular Medicine 2020.0
Bisleuconothine A protects periodontal tissue via the regulation of RANKL expression and infiltration of inflammatory cells
Tropical Journal of Pharmaceutical Research 2020.0
Inhibitors of osteoclastogenesis from Lawsonia inermis leaves
Bioorganic &amp; Medicinal Chemistry Letters 2010.0